Valuation: OraSure Technologies, Inc.

Market Cap 30Cr 26Cr 24Cr 22Cr 43Cr 2.85TCr 43Cr 288.85Cr 112.29Cr 1.4TCr 112.42Cr 110Cr 4.83TCr P/E 2026 *
-4.14x
P/E 2027 * -5.3x
Enterprise Value 30Cr 26Cr 24Cr 22Cr 43Cr 2.85TCr 43Cr 288.85Cr 112.29Cr 1.4TCr 112.42Cr 110Cr 4.83TCr EV / Sales 2026 *
2.5x
EV / Sales 2027 * 2.34x
Free-Float
93.62%
Yield 2026 *
-
Yield 2027 * -
1 day+0.69%
1 week-2.47%
Current month-2.47%
1 month+10.13%
3 months+41.23%
6 months+82.77%
Current year+79.75%
1 week 4.3
Extreme 4.3
4.54
1 month 4
Extreme 4
4.58
Current year 2.33
Extreme 2.33
4.58
1 year 2.08
Extreme 2.08
4.58
3 years 2.08
Extreme 2.08
8.45
5 years 2.08
Extreme 2.08
13.57
10 years 2.08
Extreme 2.08
23.01
Manager TitleAgeSince
Chief Executive Officer 52 04/06/2022
Director of Finance/CFO 54 08/08/2022
Chief Tech/Sci/R&D Officer - 01/12/2024
Director TitleAgeSince
Director/Board Member 59 01/06/2020
Director/Board Member 66 08/11/2021
Director/Board Member 52 04/06/2022
Date Insider Type Main position Quantity % Market Cap.
26/06Free

Director

3,666 0.0053%
03/06Free

Director

46,106 0.0670%
03/06Free

Director

46,106 0.0670%
Change 5-day change 1-year change 3-year change Capi.($)
+0.69%-2.47%+41.23%-14.03% 30Cr
+3.49%+1.36%-29.04%-11.02% 17TCr
+5.04%+2.73%-5.88%-4.53% 11TCr
+2.80%+3.63%+0.09%+55.31% 5.77TCr
+1.33%+1.39%+53.16%+49.84% 5.38TCr
+3.39%+1.39%-10.26%-39.65% 4.36TCr
+3.50%+11.11% - - 3.65TCr
+3.47%+1.58%-14.08%-43.91% 2.75TCr
+0.20%+4.24%+64.56%-3.33% 2.58TCr
+2.78%+1.17%-8.15%-0.43% 2.13TCr
Average +2.67%+4.07%+10.18%-1.31% 5.39TCr
Weighted average by Cap. +3.31%+3.80%-3.81%+1.04%

Financials

2026 *2027 *
Net sales 12Cr 10Cr 9.62Cr 8.96Cr 17Cr 1.14TCr 17Cr 115.44Cr 45Cr 560.2Cr 45Cr 44Cr 1.93TCr 13Cr 11Cr 10Cr 9.57Cr 18Cr 1.22TCr 18Cr 123.31Cr 48Cr 598.35Cr 48Cr 47Cr 2.06TCr
Net income -7.37Cr -6.44Cr -5.92Cr -5.52Cr -10Cr -701.53Cr -11Cr -71Cr -28Cr -344.84Cr -28Cr -27Cr -1.19TCr -5.76Cr -5.04Cr -4.63Cr -4.32Cr -8.19Cr -548.87Cr -8.31Cr -56Cr -22Cr -269.8Cr -22Cr -21Cr -929.71Cr
Net Debt - -
Logo OraSure Technologies, Inc.
OraSure Technologies, Inc. transforms health through actionable insight and decentralizes diagnostics to connect people to healthcare wherever they are. The Company, together with its wholly owned subsidiaries, DNA Genotek Inc. and Sherlock Biosciences, Inc., is engaged in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. Its products and services include OraQuick ADVANCE Rapid HIV 1/2 Antibody Test, OraQuick HIV Self-Test, Diagnostics Direct Syphilis Health Check, OraQuick Ebola Rapid Antigen Test, InteliSwab COVID-19 Rapid Test Pro, and SickleSCAN Test, among others. Its portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and direct consumers.
Employees
500
Date Price Change Volume
02/26/02 $4.350 +0.69% 4,31,855
01/26/01 $4.320 -3.14% 4,60,994
30/26/30 $4.460 -0.89% 5,72,538
29/26/29 $4.500 +0.90% 9,83,776
26/26/26 $4.460 +1.13% 8,71,019
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
4.350USD
Average target price
4.750USD
Spread / Average Target
+9.20%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. OSUR Stock